Big Move For BridgeBio Pharma, Inc.

Mon, Jul 17, 2023 at 07:32 PM
Big Move For BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO:NASDAQ) soared at $32.04, representing a gain of 75.9%. On Mon, Jul 17, 2023, BBIO:NASDAQ touched a New 2-Week High of $32.04. The stock appeared on our News Catalysts scanner on Mon, Jul 17, 2023 at 01:37 PM in the 'MISCELLANEOUS' category. From Mon, Jul 03, 2023, the stock recorded 66.67% Up Days and 50.00% Green Days

About BridgeBio Pharma, Inc. (BBIO:NASDAQ)

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.